Eric Boyden, MD
Adult Reconstructive Orthopaedic Surgery · Reno, NVNPI 1518948512
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,666 of the $7,102 with a category attached, or 79.8%. Smith+Nephew accounts for 79.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $5,490 and has fallen 94.0% since, to $329 in 2025.
Across 27 payments — averaging $263.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Stryker$1K
- Davol Inc.$27
- Integra Lifesciences Corporation$16
- Musculoskeletal Transplant Foundation Inc.$15
Across 22 payments — averaging $2733.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$60K
What the payments were for
- Travel & lodging$5,66680%
- Food & beverage$1,43620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $5,634 |
| Stryker | 14 | $1,410 |
| Davol Inc. | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRIGEN InterTAN$5,208
- Navio Surgical System$5,208
- MAKO$1,134
- Journey II BCS$215
- Anthology$215
- CORI$130
How this compares
Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 18 | $901 |
| Oxycodone Hcl | 88 | $481 |
| Methylprednisolone | 46 | $269 |
| Tramadol Hcl | 104 | $258 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $190 |
| Amoxicillin | 43 | $43 |
| Ondansetron Hcl | 16 | $38 |
| Meloxicam | 22 | $36 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Reno
- Michael RiesReno$7.7M
- Chad WattsReno$78K
- Jackson JonesReno$37K
- Shay WarrenReno$23K
- Kingsley OladejiReno$21K
- Sanjai ShuklaReno$21K
- Timothy OmaraReno$8K
- Steven NishiyamaLas Vegas$836K
- Parminder KangLas Vegas$26K
- Justin LimtongLas Vegas$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.